白癜风皮损浸润T细胞亚群的研究进展(3)
[4]Sandoval-Cruz，Garcia-Carrasco，Sanchez-Porras，et al.Immunopathogenesis of vitiligo[J].Autoimmunity Reviews，2011，10(12)：762-765.
[5]JG van，D Konijnenberg，TA Dellemijn，et al.Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients[J].Journal of Investigative Dermatology，2009，129(9)：2220-2232.
[6]Antelo DP，Filgueira AL，Cunha JM.Reduction of skin-homing cytotoxic T cells(CD8+ -CLA+)in patients with vitiligo[J].Photoder-matol Photoimmunol Photomed，2011，27(1)：40-44.
, http://www.100md.com
[7]Palermo B，Campanelli R，Garbelli S，et al.Specific cytotoxic Tlymphocyte responsesagainst Melan-AMART1，tyrosinase and gp100 in vitiligo by the use of major histocopatibility complexpeptide tetramers：the role of cellular immunity in the etiopathoge-gesis of vitiligo[J].Invest Dermatol，2001，117(2)：326-332.
[8]Mandelcorn-Monson RL，Shear NH，Yau E，et al.Cytotoxic T lymphocyte reactivity to gp100，Melan AMART-1，and tyrosinase，in HLA-A2-positive vitiligo patients[J].Journal of Investigative Dermatology，2003(121)：550-556.
, 百拇医药
[9]Lang KS，Caroli CC，Muhm A，et al.HLA-A2 restricted，melanocyte-specific CD8+T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against Melan AMART-1[J].Journal of Investigative Dermatology，2001(116)：891-897.
[10]EH Kemp，NG Gavalas，DJ Gawkrodger，et al.Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo[J].Autoimmunity Reviews，2007，6(3)：138-142.
, http://www.100md.com [11]K Ongenae，GN Van，JM Naeyaert.Evidence for an autoimmune pathogenesis of vitiligo[J].Pigment Cell&Melanoma Research，2003，16(2)：90-100.
[12]Wańkowicz-Kalińska A，van RM，Tigges BJ，et al.Immuno-polarization of CD4+and CD8+T cells to Type-1-like is associated with melanocyte loss in human vitiligo[J].Laboratory investigation，2003，83(5)：683-695.
[13]NH Kim，D Torchia，P Rouhani，et al.Tumor necrosis factor-α in vitiligo：direct correlation between tissue levels and clinical parameters[J].Cutaneous&Ocular Toxicology，2011，30(3)：225-227.
, 百拇医药
[14]Lv Y，Li Q，Wang L，et al.Use of anti-tumor necrosis factor agents：apossible therapy for vitiligo[J].Medical Hypotheses，2009(72)：546-547.
[15]Galadari I.Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE[J].Eur Ann Allergy&Clin Immunol，2005(37)：109-111.
[16]Franczuk A，Szepietowski JC，Noworolska A.Serum concentrationsof interleukin-2 soluble receptor(IL-2 sR)in patients with vitiligo：relationship with type and extent of the disease[J].Acta Dermatovenerologica Croatica，2004(12)：71-76.
, http://www.100md.com
[17]Y Kotobuki，A Tanemura，L Yang，et al.Dysregulation of me-lanocyte function by Th17-related cytokines：significance of Th17 cell infiltration in autoimmune vitiligo vulgaris[J].Pigment Cell Melanoma Res，2012，25(2)：219-230.
[18]DA Bassiouny，O Shaker.Role of interleukin-17 in the pathogenesis of vitiligo[J].Clinical and Experimental Dermatology，2011，36(3)：292-297.
[19]Wang CQ，Cruz-Inigo AE，Fuentes-Duculan J，et al.Th17 cells and activated dendritic cells are increased in vitiligo lesions[J].PLoS One，2011(6)：e18907.
[20]Fontenot，Rasmussen，P Jeffrey，et al.Regulatory T cell lineage specification by the forkhead transcription factor foxp3[J].Immunity，2005，22(3)：329-341.編辑/成森, http://www.100md.com(戴远洋 宋鹏飞 王京)
[5]JG van，D Konijnenberg，TA Dellemijn，et al.Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients[J].Journal of Investigative Dermatology，2009，129(9)：2220-2232.
[6]Antelo DP，Filgueira AL，Cunha JM.Reduction of skin-homing cytotoxic T cells(CD8+ -CLA+)in patients with vitiligo[J].Photoder-matol Photoimmunol Photomed，2011，27(1)：40-44.
, http://www.100md.com
[7]Palermo B，Campanelli R，Garbelli S，et al.Specific cytotoxic Tlymphocyte responsesagainst Melan-AMART1，tyrosinase and gp100 in vitiligo by the use of major histocopatibility complexpeptide tetramers：the role of cellular immunity in the etiopathoge-gesis of vitiligo[J].Invest Dermatol，2001，117(2)：326-332.
[8]Mandelcorn-Monson RL，Shear NH，Yau E，et al.Cytotoxic T lymphocyte reactivity to gp100，Melan AMART-1，and tyrosinase，in HLA-A2-positive vitiligo patients[J].Journal of Investigative Dermatology，2003(121)：550-556.
, 百拇医药
[9]Lang KS，Caroli CC，Muhm A，et al.HLA-A2 restricted，melanocyte-specific CD8+T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against Melan AMART-1[J].Journal of Investigative Dermatology，2001(116)：891-897.
[10]EH Kemp，NG Gavalas，DJ Gawkrodger，et al.Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo[J].Autoimmunity Reviews，2007，6(3)：138-142.
, http://www.100md.com [11]K Ongenae，GN Van，JM Naeyaert.Evidence for an autoimmune pathogenesis of vitiligo[J].Pigment Cell&Melanoma Research，2003，16(2)：90-100.
[12]Wańkowicz-Kalińska A，van RM，Tigges BJ，et al.Immuno-polarization of CD4+and CD8+T cells to Type-1-like is associated with melanocyte loss in human vitiligo[J].Laboratory investigation，2003，83(5)：683-695.
[13]NH Kim，D Torchia，P Rouhani，et al.Tumor necrosis factor-α in vitiligo：direct correlation between tissue levels and clinical parameters[J].Cutaneous&Ocular Toxicology，2011，30(3)：225-227.
, 百拇医药
[14]Lv Y，Li Q，Wang L，et al.Use of anti-tumor necrosis factor agents：apossible therapy for vitiligo[J].Medical Hypotheses，2009(72)：546-547.
[15]Galadari I.Serum levels of the soluble interleukin-2 receptor in vitiligo patients in UAE[J].Eur Ann Allergy&Clin Immunol，2005(37)：109-111.
[16]Franczuk A，Szepietowski JC，Noworolska A.Serum concentrationsof interleukin-2 soluble receptor(IL-2 sR)in patients with vitiligo：relationship with type and extent of the disease[J].Acta Dermatovenerologica Croatica，2004(12)：71-76.
, http://www.100md.com
[17]Y Kotobuki，A Tanemura，L Yang，et al.Dysregulation of me-lanocyte function by Th17-related cytokines：significance of Th17 cell infiltration in autoimmune vitiligo vulgaris[J].Pigment Cell Melanoma Res，2012，25(2)：219-230.
[18]DA Bassiouny，O Shaker.Role of interleukin-17 in the pathogenesis of vitiligo[J].Clinical and Experimental Dermatology，2011，36(3)：292-297.
[19]Wang CQ，Cruz-Inigo AE，Fuentes-Duculan J，et al.Th17 cells and activated dendritic cells are increased in vitiligo lesions[J].PLoS One，2011(6)：e18907.
[20]Fontenot，Rasmussen，P Jeffrey，et al.Regulatory T cell lineage specification by the forkhead transcription factor foxp3[J].Immunity，2005，22(3)：329-341.編辑/成森, http://www.100md.com(戴远洋 宋鹏飞 王京)
参见：首页 > 医疗版 > 疾病专题 > 皮肤科 > 色素障碍性皮肤病(色素沉着) > 白癜风